NovoCure Ltd. (NVCR)
13.02
-0.62
(-4.58%)
USD |
NASDAQ |
Jan 20, 16:00
12.84
-0.18
(-1.34%)
After-Hours: 20:00
NovoCure EPS Diluted (Quarterly): -0.333 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| LivaNova Plc | 0.4856 |
| Perspective Therapeutics, Inc. | -0.3495 |
| InfuSystem Holdings, Inc. | 0.1078 |
| Xtant Medical Holdings, Inc. | 0.0087 |
| VolitionRX Ltd. | -0.0497 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -37.27M |
| Revenue (Quarterly) | 167.20M |
| Total Expenses (Quarterly) | 204.47M |
| Enterprise Value | 1.289B |
| Gross Profit Margin (Quarterly) | 73.25% |
| Profit Margin (Quarterly) | -22.29% |
| Earnings Yield | -12.38% |
| Normalized Earnings Yield | -12.34 |